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SIntroduction
In the United States, squamous cell carcinoma of the head
and neck compromises about 4% of all malignancies. This
corresponds to an estimated 17 per 100000 persons with
newly diagnosed squamous cell carcinoma of the head and
neck per year. Male-to-female incidence rates are greater
than 2:1. The discrepancy in male-to-female ratio is even
more pronounced in laryngeal tumors, in which carcinoma
is 4–5 times more common in men. This ratio has declined
in the last 20 years, possibly reflecting the increased num-
ber of women using tobacco products during this period.1741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reserved
oi:10.1016/j.ooe.2005.12.001
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hetty).Laryngeal cancer generally is a disease of the elderly, with
a peak incidence in the 1950s and 1960s. In certain parts
of India and Southeast Asia, the practice of mixing cured to-
bacco with betel nuts has been associated with head and
neck cancers. More than 200 million persons are thought
to engage in this practice worldwide.1 A resultant 2.8 times
higher relative risk of cancer exists for these individuals,
and this increases to more than 10 times when smoking is
also practiced. In Brazil and other developing countries,
head and neck cancer represents 35% of all malignancies.1,2
HIV has indirectly claimed the lives of over 3 million peo-
ple to date, and over 40 million people worldwide are cur-
rently HIV infected (Joint United Nations Program on HIV/
AIDS, 2002 statistics, www.unaids.org). HIV preferentially
infects CD4+ T lymphocytes, resulting in a progressive
depletion of these cells. This leads to immunodeficiency.
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infections.
The etiology of this carcinoma is most commonly associ-
ated with the use of alcohol and tobacco. The risk for oral
cancer is additive and is 15 times greater than in those
who neither smoke nor drink.2 In squamous cell carcinoma,
mutations in the p53 gene correlate with drinking and smok-
ing habits. Some 15% of patients have a viral etiology.3
Epstein–Barr virus (EBV) has been implicated in the devel-
opment of nasopharyngeal carcinoma.
Human papillomavirus infection is another factor impli-
cated in the carcinogenesis of upper aerodigestive tract tu-
mors.3 In particular, human papillomavirus-16 can be
isolated in 36% of oral cavity cancers.
Environmental exposures to paint fumes, plastic byprod-
ucts, wood dust, asbestos, and gasoline fumes have been
implicated as risk factors. Gastroesophageal reflux disease
is now thought to be a significant risk factor cancer of the
larynx and especially the anterior two thirds of the vocal
cords. Irritation from poorly fitting dentures also has been
implicated.2 Squamous cell carcinoma is though to arise
from keratinizing or malpighian epithelial cells. The hall-
mark of squamous cell carcinoma is the presence of keratin
or ‘‘keratin pearls’’ on histologic evaluation.2,3 These are
well-formed desmosome attachments and intracytolasmic
bundles of keratin tonofilaments. The term epidermoid
can be substituted for squamous. Morphologically, it is var-
iable and may appear as plaques, nodules, or verrucae.
These in term may be scaly or ulcerated, white, red or
brown. Verrucous carcinoma has a more favorable prognosis
because of infrequent nodal and distant metastasis.2
Clinical presentation of this malignant neoplasm usually
begins as surface lesions with erythema and slight elevation.
These lesions are termed erythroplasia and deserve
biopsy.1,2 These early red lesions are asymptomatic and
may be either carcinoma in situ or invasive carcinoma.
One third of lesions are pure white; they are known as leu-
koplakia but only 10% of them are carcinoma in situ or inva-
sive carcinoma1 The most common sites for squamous cell
carcinoma are the floor of the mouth, the tongue, soft pal-
ate, anterior tonsillar pillar, and the retromolar region.
Tender, painful lesions usually are suggestive of perineural
invasions. When lesions become palpable masses, symptoms
such as vague persistent sore throat or ear infection occur.2
In more advanced cases, dissemination to ipsilateral sub-
mandibular and jugulodigastric nodes is common, and the
patient may present with a mass in the neck. When lymph
node or remote bone and organ metastases are associated
with an early oral primary lesion, often a second, more ad-
vanced primary upper aerodigestive or lung cancer is
responsible for the metastasis.4
Treatment approaches to SCCA incorporate surgery,
radiotherapy, chemotherapy, and combinations of these.
New investigative treatments include immunotherapy and
gene therapy. Factors that influence the choice of treatment
are the site, grade, and stage of the primary tumor, patient
age, and general medical condition.5 Goals of treatment
generally consist of removal of cancer load, maintenance
of quality of life, and prevention of subsequent primaries.5
Differential diagnosis of SCCA include solitary radiolu-
cencies with diffuse irregular borders such as chronic alve-
olar abscess, chronic osteomyelitis, osteoradionecrosis,metastatic tumors to the jaws, fibrous dysplasia (early
stage), histiocytosis X, osteosarcoma and chondrosarcoma,
ewing’s sarcoma and burkitt’s lymphoma.6
This case report demonstrates the importance of taking
proper preventive measurements in order to avoid the
development of osteoradionecrosis in an HIV positive pa-
tient with history of radiation therapy post SCCA.Case report
A 64-year-old African-American male presented to the HIV
outpatient clinic facility complaining of moderate to severe
pain in his lower left mandibular quadrant since approxi-
mately three weeks. The patient stated that approximately
three months ago he had a back tooth in the left extracted,
and since then, progressive changes including pain started
to arise. The patient’s medical history was significant for
previous history of squamous cell carcinoma of the larynx
in 2002 treated with radiation therapy approximately three
years ago. A surgical pathology consultation report showed
invasive squamous cell carcinoma of the right anterior and
posterior true vocal cords; the left vocal cord appeared with
severe dysplasia but no evidence of invasive SCCA. The pa-
tients transglottic neck area and mandibular angles of the
mandible bilaterally (Fig. 1) were irradiated for approxi-
mately six weeks, receiving in fractionation a total of
7440 centigrays, totalling 61 BID radiation sessions during
this six week course.
The panorex radiograph revealed mottled areas of radio-
lucency with nonsclerotic areas at the edge of the involve-
ment (Fig. 2). A PA film was ordered as an additional
diagnostic aid which clearly showed the presence and ex-
tent of a pathological fracture and mandibular discontinuity
along the left mandibular border (Fig. 3). A previous pano-
rex taken approximately four months ago prior to the event
of the tooth extraction showed no evidence of existing le-
sion and lead to the suspicion that trauma induced ORN
was provoked (Fig. 4).
The patient stated that he had seeked attention to have
the tooth extracted because of untolerated pain, as well as
discomfort upon mastication due to the high mobility of the
involved tooth. An incisional biopsy was performed to rule
out the possibility of a metastatic malignancy. The extraoral
exam showed slight facial asymmetry with discontinuity of
the left mandibular border upon palpation (Fig. 5). Changes
in facial skin texture including discoloration, permanent
hair loss, and scaring of the skin were observed, all which
are late reactions seen in skin after radiation therapy
(Fig. 6). No lymphadenopathy or extraoral fistula were de-
tected. Intraoral exam showed extreme tenderness upon
palpation extending from the previous extraction site of left
mandibular molar to the left mandibular first premolar. Ery-
thema of the surrounding tissue, along with halitosis, gener-
alized radiation caries, xerostomia, and poor oral hygiene
were also present. Trismus was present with a constricted
oral opening of approximately 10 mm.
The patient was instructed to avoid alcohol, smoking, hot
or cold foods, and all prosthodontic appliances in conjunc-
tion with a protected course of systemic antibiotics (tetra-
cycline), oral rinses, and analgesics. Counseling on home
care and stretching exercises were also given.
Figure 1 Zones documenting the transglottic neck area and mandibular angles bilaterally receiving radiation therapy.
Figure 3 PA Film clearly showing the presence and extent of
a pathologic fracture along the left mandibular border area.
Figure 2 Panoramic radiograph revealing mottled areas of
radiolucency with nonsclerotic areas at the edge of the
involvement (left).
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The HIV/AIDS pandemic has become a human, social, and
economic disaster with far reaching implications for individ-
uals, communities, and countries. No other disease has so
dramatically highlighted the disparities and inequities in ac-
cess to health care, economic opportunity, and the protec-
tion of basic human right.
Radiotherapy is a major defense against squamous cell
carcinoma and other such diseases. Its use is ideally pre-
dicted on the ability of the radiation to destroy neoplastic
cells while sparing normal cells. In practice, however, this
is never actually achieved, and normal tissue experience
some undesirable effects. Any neoplasm can be destroyed
by radiation if the dose delivered to the neoplastic cells is
sufficient. The limiting factor is the amount of radiation
that the surrounding tissues can tolerate.7
Early in the course of radiotherapy, the oral mucosa,
shows the effects of treatment. The changes in and around
the oral cavity as the result of destruction are most notable
to dentistry.7 Salivary glands and bone are relatively radio-
resistant, these tissues bear a considerable hardship in the
long run.7 The special care dentist needs a strong under-
standing of these sequelae in order to best treat patients.
Some of the oral complications to radiation therapy
include oral mucositis, xerostomia, fungal infections,
increase caries (radiation caries), abnormal dental devel-
opment, trismus, functional disabilities, nutritional com-
promise, dysphagia, soft tissue necrosis, scar tissue
formation, and osteoradionecrosis. Every single one of
these complications should be attacked aggressively in or-
der to diminish the severity of the side effects encountered
post-radiation treatment.
One of the most severe and complicating sequelae of X-
ray treatment for patients with head and neck cancer is
osteoradionecrosis (ORN). Basically, osteoradionecrosis is
devitalization of the bone by cancericidal doses of radia-
tion. The bone within the radiation beam becomes virtually
nonvital from an endarteritis that results in elimination of
the fine vasculature within the bone.7 The turnover rate
of any remaining viable bone is slowed to the point of being
ineffective in self-repair. The continual process of remodel-
ing normally found in bone does not occur, and sharp areas
Figure 4 Panorex radiograph taken approximately four months prior to the event of tooth extraction showing no evidence of
existing lesion.
Figure 5 Discontinuity of left mandibular border was evident
during extraoral examination.
Figure 6 Changes in facial skin texture including discolor-
ation, permanent hair loss, and scaring were observed.
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considerable time. The bone of the mandible is denser and
has a poorer blood supply than the maxilla.7 Thus the man-
dible is the jaw most commonly affected with nonhealing
ulcerations and osteoradionecrosis.
The pathophysiology of ORN is best illustrated by the
three ‘‘H’’ principle which describes the effect of radiation
on tissue as presented in the landmark article by Marx. Radi-
ation leads to progressively hypocellular, hypovascular, and
hypoxic tissues.8 This impedes the replacement of connec-
tive tissue turnover in normal homoestasis and in woundhealing.9 Breakdown of tissue can thus ensue with or with-
out trauma. ORN is, therefore, a problem of impaired and
inadequate tissue turnover and wound healing.9,10
Clinically, there are three types of ORN. Type I is trauma-
induced ORN which occurs early with surgical wounding and
radiation therapy in close proximity. The most common is
type II, also trauma induced ORN, which occurs years after
radiation therapy. Type III or spontaneous ORN can occur
anytime after radiotherapy without any obvious preceding
surgical or traumatic event.9–11
Clinical sign and symptoms of ORN are often associated
with the development of oral-cutaneous fistula, exposed
bone, trismus, masticatory difficulties, pain and swelling.
The patient may have a foul odor due to the accumulation
of debris in the defect and exposure of the bone to oral
fluids.12 Exposed bone is usually covered by grayish-yellow
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lar bed with a brownish-yellow color.
The mucosa overlying the bony lesion will frequently
have an ulcerated, rolled border that may bleed when
probed. Radiographically, ORN will present as an erosion
of the cortical surface with an underlying, poorly cir-
cumscribed, radiolucency with nonsclerotic borders.13
Interspersed radiopacities, which represent sequestrum for-
mation, may be seen. Pathological fractures may also occur
in the affected bone.
Contributing factors to the development of ORN are well
known and include dental trauma, the premorbid state of
the dentition, anatomic location of the lesion (tongue, floor
of the mouth, retromolar region have a higher incidence of
ORN), radiation dosage, delivery and fractionation, elapsed
time since radiation, nutrition, alcohol and tobacco use,
concomitant surgery and chemotherapy.12–14
In order to prevent the occurrence of post radiation ORN,
finding and treating oral problems before anticancer ther-
apy begins can prevent or lessen the severity of oral compli-
cations. Oral complications in patients undergoing
treatment for head and neck cancer may be reduced by
aggressive prevention measures taken before treatment
begins.
Included in our pre-radiation recommendations are to
identify and treat existing infections, carious and other
compromised teeth, tissue injury or trauma. Stabilize or
eliminate potential sites of infection. Conduct a prosth-
odontic evaluation if necessary. Remove orthodontic bands
and brackets if present. In children, consider extracting
highly mobile primary teeth and teeth that are expected
to exfoliate during treatment. In adults, extract teeth that
may pose a future problem or are non restorable to prevent
later extraction induced osteonecrosis. If removal of teeth
is indicated before radiation treatment, the principles of
atraumatic exodontias apply.7 The teeth are to be removed
in a surgical manner with flap reflection, alveoloplasty and
primary soft tissue closure without tension.7 Oral surgery
procedures are to be performed at least three weeks before
radiation therapy begins, if possible.15 This helps to ensure
that sufficient soft tissue healing has occurred. If a local
wound dehiscence has occurred, radiotherapy should be de-
layed further. In this instance daily local wound care with
irrigation and postoperative antibiotics are mandatory until
the soft tissue have healed. Of critical importance to men-
tion is that the clinician in these circumstances is in a race
against time. If the wound fails to heal, radiation therapy
will be delayed. If this radiation is delivered before the
wound heals, healing will take months or even years.7
Finally, the patient should begin a home-care program
which would include the use of topical fluoride, antimicro-
bial mouth rinses, and proper brushing and flossing tech-
nique. Once radiation therapy is concluded, the patient
should immediately begin treatment for mucositis, oral dry-
ness, and hyposalivation. Range of motion exercises to pre-
vent trismus and nutritional counseling should be
encouraged.12–15
Over the years, osteoradioncerosis has been treated by
numerous methods with less than ideal results and variable
success rates. Although still considered controversial by
some, hyperbaric oxygen (HBO) therapy used as an adjunc-
tive treatment for ORN has been associated with improvedsuccess rates.17–19 There are also reports that HBO has pro-
vided beneficial results when used prophylactically for the
extraction of teeth in patients deemed to be at risk for
developing ORN, although this success is disputed by
some.20
HBO therapy is a treatmentmodality which provides an in-
crease oxygen tension at the tissue level to promote healing,
especially in wounds with a compromised vasculature It im-
proves tissue healing by increasing the oxygen gradient in
irradiated tissues. In normal nonirradiated wounds, there is
a central area of tissue injury surrounded by tissue with nor-
mal perfusion, setting up a steep oxygen gradient across the
wound. Such gradients have been shown to be the physical
chemotactic factor attracting macrophages to a wound.21,22
Lactate, iron and steep oxygen gradients stimulate macro-
phage-derived angiogenesis factor and macrophage-derived
factor, which in turn promote capillary budding and collagen
synthesis in wounds.21 However, in wounds with radiation tis-
sue injury, which inevitably results in diffuse damage, only
shallow oxygen gradients are created. The stimulus for fibro-
plasias and angiogenesis is therefore lacking. HBO restores
the steep oxygen gradient needed for wound healing.21–23
Many authors have reported on the positive tissue effects of
HBO therapy.24–26 Treatment is accomplished by placing
the patient in a pressure-tolerant chamber, either alone
(monoplace chamber), or with more than one patient or a
therapist (in a multichamber). The chamber is pressurized
at 2.4 atm absolute and, depending on the protocol, patients
remain inside for 90 min.7 The current protocol for the treat-
ment of mandibular ORN according to Marx consists of per-
forming 30 HBO dive (1 dive per day, Monday–Friday) at
2.4 atm form 90 min.27 Reassess the patient to evaluate de-
crease bone exposure, granulation tissue covering exposed
bone, resorption of nonviable bone, and absence of inflam-
mation. For patients who respond favorably, continue treat-
ment for a total of 40 dives (stage I).27 For patients who are
not responsive, advance to stage II. In this second phase,
transoral sequestrectomy with primary wound closure fol-
lowed by continued HBO to a total of 40 dives would be indi-
cated.28 If wound dehiscence occurs, advance the patient to
stage III. Patients who present with orocutaneous fistula,
pathologic fracture, or resorption to the inferior border of
the mandible advance to stage III immediately after the ini-
tial 30 dives. In stage III, perform transcutaneous mandibular
resection, wound closure, and mandibular fixation, followed
by an additional 10 postoperative HBO dives.29 Finally, pro-
ceed with mandibular reconstruction 10 weeks after success-
ful resolution of mandibular ORN.29
Unplanned but required surgery in previously irradiated
tissue is fraught with a known big incidence of potentially
fatal complications. Prophylactically HBO has changed this
picture. Marx et al showed a statistically significant reduc-
tion in the development of ORN after tooth removal, i.e.,
29.9% of patients receiving penicillin in the perioperative
extraction (extraction) phase developed ORN versus only
5.4% in the HBO-treated group.11 HBO can prevent most of
ORN if used in a planned manner, in coordination with the
treating surgeon. Education, supportive care, and the treat-
ment of symptoms are important for patients who have oral
complications related to radiation therapy. Patients should
be closely monitored for pain, ability to cope, and response
to treatment.
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severity of these complications can be reduced. The best
approach for the management of these patients is preven-
tion. A careful clinical and radiographic exam of the oral
cavity pre-treatment will reveal any alteration in soft tis-
sues, periodontal apparatus, teeth and bone. The oral entity
must be brought to a healthy status before radiation therapy
whenever possible. There is no one pre-radiation orodental
treatment planning for all the patients. Each patient is a un-
ique case that must be dealt according to the individuals
need.
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